US Health Department to review information from Medicare and Medicaid recipients with autism, according to RFK Jr.

Health Secretary Announces Autism Research Using Medicaid and Medicare Data

WASHINGTON — Health Secretary Robert F. Kennedy Jr. revealed plans on Wednesday to leverage medical data from individuals enrolled in Medicaid and Medicare to advance research on autism. However, experts express skepticism about the potential to unearth the true causes of the condition.

The initiative involves data-sharing agreements between the National Institutes of Health and the Centers for Medicare and Medicaid Services, which together have access to billing data related to approximately 150 million Americans.

“We are using this partnership to identify the root causes of autism and other chronic diseases,” Kennedy stated.

According to a statement from the Department of Health and Human Services (HHS), the agreement will adhere to relevant privacy laws designed to protect sensitive health information. The health department has not provided further comments or clarifications regarding the program.

Researchers intend to analyze trends in autism diagnoses, outcomes related to medical and behavioral treatments, access based on demographics and geography, as well as the financial implications for families and healthcare systems.

However, Helen Tagger Fulsberg, a Boston University professor who leads a coalition of autism researchers, argues that the provided data may not address fundamental questions about autism’s causes. “At this point, there’s enough research to understand that there’s no simple solution,” she mentioned, noting that this dataset is inadequate for exploring genetic factors or early life influences that are crucial.

Kennedy has mandated the health department to undertake various research initiatives aimed at pinpointing autism’s origins, acknowledging its complex nature. He previously announced that he aims to deliver insights into these causes by September, hinting at identifying at least some contributing factors.

This directive comes amidst rising autism rates in the U.S., as reported by the Centers for Disease Control and Prevention. The latest report indicates that one in 31 children in the country is affected by autism, a significant rise since 2020. Scientists attribute this increase in diagnoses to greater awareness, particularly regarding individuals showing milder symptoms.

In public statements, Kennedy has rejected the narrative of increased awareness, labeling autism as a “preventable disease” linked to environmental influences. Traditionally, autism is categorized as a complex brain disorder rather than a disease, and despite extensive research, a single definitive cause remains elusive. Genetic factors are recognized, but research also points to numerous contributing elements, such as paternal age, maternal weight, diabetes, and exposure to specific chemicals.

Kennedy’s remarks have raised concerns among autism researchers and advocates, especially regarding the potential reinforcement of the debunked theory that vaccines contribute to autism. He has previously promoted this idea, yet extensive studies have found no evidence supporting a link between vaccines and the condition. Former President Donald Trump has also suggested that vaccines might relate to rising autism rates.